• Konstantinos Spengos, Georgios Tsivgoulis, and Nikolaos Zakopoulos.
• Department of Neurology, University of Athens School of Medicine, Eginition Hospital, Greece. spengos@hol.gr
• Eur. Neurol. 2006 Jan 1; 55 (3): 123-35.

AbstractAlthough elevated blood pressure (BP) levels are a common complication of acute stroke, whether of ischaemic or haemorrhagic type, a long-standing debate exists regarding the management of post-stroke hypertension. In the absence of solid, randomised data from controlled trials, the current observational evidence allows different approaches, since theoretical arguments exist for both lowering BP in the setting of acute stroke (reduce the risk of stroke recurrence, of subsequent oedema formation, of rebleeding and haematoma expansion in patients with cerebral bleeding) as well as leaving raised BP levels untreated (avoid reduction in cerebral perfusion pressure and blood flow to viable ischaemic tissue in the absence of normal autoregulation). The present review will summarize the evidence for and against the therapeutic manipulation of BP in acute stroke provided by the currently available observational studies and randomised trials, consider the ongoing clinical trials in this area and address the present recommendations regarding this conflicting issue.Copyright 2006 S. Karger AG, Basel.

19 keywords...

hide…